Serum sex hormones and measures of benign prostatic hyperplasia

Prostate

Volumn 61, Issue 2, 2004, Pages 124-131

  Roberts, Rosebud O ^a,c   Jacobson, Debra J ^a   Rhodes, Thomas ^b   Klee, George G ^a   Leiber, Michael M ^a   Jacobsen, Steven J ^a  

^a Mayo Clinic   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Benign prostatic hyperplasia; Cross sectional; Peak flow rate; Prostate volume; Sex hormones; Symptoms

Indexed keywords

ESTRADIOL; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE; TESTOSTERONE;

ADULT; AGED; ARTICLE; BIOAVAILABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ESTRADIOL BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL; TRANSRECTAL ULTRASONOGRAPHY; UNITED STATES; URINE FLOW RATE;

ADULT; AGED; BODY WEIGHTS AND MEASURES; COHORT STUDIES; ESTRADIOL; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; TESTOSTERONE;

EID: 4544286647     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20080     Document Type: Article

References (26)

1. Wilson JD. The pathogenesis of benign prostatic hyperplasia. Am J Med 1980;68:745-756.
2. Thigpen AE, Davis DL, Gautier T, Imperato-McGinley J, Russell DW. Brief report: The molecular basis of steroid 5alpha-reductase deficiency in a large Dominican kindred. N Engl J Med 1992;327:1216-1219.
3. Weihua Z, Makela S, Andersson LC, Salmi S, Saji S, Webster JI, Jensen EV, Nilsson S, Warner M, Gustafsson JA. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA 2001;98:6330-6335.
4. Smith P, Rhodes NP, Ke Y, Foster CS. Upregulation of estrogen and androgen receptors modulate expression of FGF-2 and FGF-7 in human, cultured, prostatic stromal cells exposed to high concentrations of estradiol. Prostate Cancer Prostatic Dis 2002;5:105-110.
5. Von Schoultz V, Carlström K. On the regulation of sex hormone-binding globulin-A challenge of an old dogma and outlines of an alternative mechanism. J Steroid Biochem 1989;32:327-334.
6. Farnsworth WE. Estrogen in the etiopathogenesis of BPH. Prostate 1999;41:263-274.
7. Gupta C. The role of estrogen receptor, androgen receptor and growth factors in diethylstilbestrol-induced programming of prostate differentiation. Urol Res 2000;28:223-229.
8. Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol 1991;145:405-409.
9. Rannikko S, Adlercreutz H. Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer. Prostate 1983;4:223-229.
10. Gann PH, Hennekens CH, Longcope C, Verhoek-Oftedahl W, Grodstein F, Stampfer MJ. A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia. Prostate 1995;26:40-49.
11. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM. The prevalence of prostatism: A population-based survey of urinary symptoms. J Urol 1993;150:85-89.
12. Jacobsen SJ, Guess HA, Panser L, Girman CJ, Chute CG, Oesterling JE, Lieber MM. A population-based study of health care-seeking behavior for treatment of urinary symptoms: The Olmsted County Study of urinary symptoms and health status among men. Arch Fam Med 1993;2:729-735.
13. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am 1981;245:54-63.
14. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-274.
15. Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, Lieber MM. Natural history of prostatism: Risk factors for acute urinary retention. J Urol 1997;158:481-487.
16. Barry MJ, Fowler FJJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett ATK, Measurement Committee of the American Urological Association T. The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. J Urol 1992;148:1549-1557.
17. Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol 1991;145:984-987.
18. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM. Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges. JAMA 1993;270:860-864.
19. Hulka BS, Hammond JE, DiFerdinando G, Mickey DD, Fried FA, Checkoway H, Stumpf WE, Beckman WCJ, Clark TD. Serum hormone levels among patients with prostatic carcinoma or benign prostatic hyperplasia and clinic controls. Prostate 1987;11:171-182.
20. Suzuki K, Inaba S, Takeuchi H, Takezawa Y, Fukabori Y, Suzuki T, Imai K, Yamanaka H, Honma S. Endocrine environment of benign prostatic hyperplasia. Relationships of sex steroid hormone levels with age and the size of the prostate. Japanese J Urol 1992;83:664-671.
21. Platz EA, Kawachi I, Rimm EB, Longcope C, Stampfer MJ, Willett WC, Giovannucci E. Plasma steroid hormones, surgery for benign prostatic hyperplasia, and severe lower urinary tract symptoms. Prostate Cancer Prostatic Dis 1999;2:285-289.
22. Meikle AW, Stephenson RA, Lewis CM, Middleton RG. Effects of age and sex hormones on transition and peripheral zone volumes of prostate and benign prostatic hyperplasia in twins. J Clin Endocrinol Metabol 1997;82:571-575.
23. Suzuki K, Ito K, Ichinose Y, Kurokawa K, Suzuki T, Imai K, Yamanaka H, Honma S. Endocrine environment of benign prostatic hyperplasia: Prostate size and volume are correlated with serum estrogen concentration. Scand J Urol Nephrol 1995;29:65-68.
24. Wennberg J, Gittelsohn A. Small area variations in health care delivery. Science 1973;182:1102-1108.
25. Panser LA, Chute CG, Guess HA, LarsonKeller JJ, Girman CJ, Oesterling JE, Lieber MM, Jacobsen SJ. The natural history of prostatism: The effects of non-response bias. Int J Epidemiol 1994;23:1198-1205.
26. Roberts RO, Lieber MM, Rhodes T, Girman CJ, Bostwick DG, Jacobsen SJ. Prevalence of a physician-assigned diagnosis of prostatitis: The Olmsted County Study of urinary symptoms and health status among men. Urology 1998;51:578-584.